Pachymic acid modified carbon nanoparticles reduced angiogenesis via inhibition of MMP-3

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 5464-5470

  Ma, Jun ^a   Liu, Jun ^a   Lu, Chun Wei ^a   Cai, Ding Fang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Metalloproteinase 3; Metastasis; Multi walled nanotubes

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBON; MATRIX METALLOPROTEINASE INHIBITOR; NANOPARTICLE; PACHYMIC ACID; STROMELYSIN; TRITERPENE;

ANIMAL; CHICKEN; CHORIOALLANTOIS; DRUG EFFECTS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

ANGIOGENESIS INHIBITORS; ANIMALS; CARBON; CHICKENS; CHORIOALLANTOIC MEMBRANE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE INHIBITORS; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; TRITERPENES;

EID: 84937781891     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Adams RH and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007; 8: 464-478.
2. Kurz H, Burri PH and Djonov VG. Angiogenesis and vascular remodeling by intussusception: from form to function. News Physiol Sci 2003; 18: 65-70.
3. Ambler CA, Schmunk GM and Bautch VL. Stem cell-derived endothelial cells/progenitors migrate and pattern in the embryo using the VEGF signaling pathway. Dev Biol 2003; 257: 205-219.
4. Dorrell MI and Friedlander M. Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog Retin Eye Res 2006; 25: 277-295.
5. Ferrara N, Gerber HP and LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
6. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006; 39: 469-478.
7. Dudley AC. Tumor endothelial cells. Cold Spring Harb Perspect Med 2012; 2: a006536.
8. Magnusson PU, Dimberg A, Mellberg S, Lukinius A and Claesson-Welsh L. FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin. Blood 2007; 110: 4214-4222.
9. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-7.
10. Ilina O and Friedl P. Mechanisms of collective cell migration at a glance. J Cell Sci 2009; 122: 3203-3208.
11. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H and Shirasuna K. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis. Head Neck 1999; 21: 627-38.
12. Sato H and Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 1996; 119: 209-215.
13. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL and Quigley JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999; 274: 13066-13076.
14. Tripathi CKM, Banga J and Mishra V. Microbial heparin/heparan sulphate lyases: potential and applications. Appl Microbiol Biotechnol 2012; 94: 307-321.
15. Azad N, Posadas E, Kwitkowski V, Annunziata C, Barrett T, Premkumar A, Kotz H, Sarosy G, Minasian L and Kohn E. Increased efficacy and toxicity with combination anti-VEGF therapy using sorafenib and bevacizumab. J Clin Oncol 2006; 24: 3004.
16. Wierzbicki M, Sawosz E, Grodzik M, Prasek M, Jaworski S and Chwalibog A. Comparison of anti-angiogenic properties of pristine carbon nanoparticles. Nanoscale Res Lett 2013; 8: 195.
17. Portney NG and Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 2006; 384: 620-630.
18. Murugesan S, Mousa SA, O'connor LJ, Lincoln DW and Linhardt RJ. Carbon inhibits vascular endothelial growth factor-and fibroblast growth factor-promoted angiogenesis. FEBS Lett 2007; 581: 1157-1160.
19. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi JH, Claesson-Welsh L and Alitalo K. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1998; 95: 14389-14394.
20. Plate KH, Breier G, Weich HA and Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-8.
21. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
22. Hicklin DJ and Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011-1027.
23. Breier G, Albrecht U, Sterrer S and Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521-532.
24. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135-1135.
25. Heppner KJ, Matrisian LM, Jensen RA and Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996; 149: 273.
26. Mercapide J, Lopez De Cicco R, Castresana JS and Klein-Szanto AJ. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. Int J Cancer 2003; 106: 676-682.
27. Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS and Matrisian LM. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol 2000; 20: 5828-5839.
28. Monvoisin A, Bisson C, Si-Tayeb K, Balabaud C, Desmoulière A and Rosenbaum J. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer 2002; 97: 157-162.
29. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T and Morimatsu M. Production onf matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992; 70: 2747-2753.
30. Wang H and Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle Cells role of Flt-1. Circ Res 1998; 83: 832-840.
31. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E and Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 2002; 277: 36288-36295.
32. Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P and Yan L. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005; 65: 3193-3199.
33. Zhang M, Volpert O, Shi YH and Bouck N. Maspin is an angiogenesis inhibitor. Nat Med 2000; 6: 196-199.